REFERENCES
- Uchino S, Bellomo R, Morimatsu H, . Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33:1563–1570.
- Vanholder R, Van Biesen W, Lameire N. What is the renal replacement method of first choice for intensive care patients? J Am Soc Nephrol. 2001;12:S40–S43.
- Ronco C, Cruz D, Bellomo R. Continuous renal replacement therapy in critical illness. Contrib Nephrol. 2007;156:309–319.
- Schetz M. Vascular access for IHD and CRRT. Contrib Nephrol. 2007;156:275–286.
- Wentling AG. Hemodialysis catheters: materials, design and manufacturing. Contrib Nephrol. 2004;142:112–127.
- Savader SJ, Haikal LC, Ehrman KO, Porter DJ, Oteham AC. Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion. J Vasc Interv Radiol. 2000;11:1131–1136.
- Oliver MJ, Mendelssohn DC, Quinn RR, . Catheter patency and function after catheter sheath disruption: a pilot study. Clin J Am Soc Nephrol. 2007;2:1201–1206.
- Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters – an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant. 2007;22:471–476.
- Vanholder R. Vascular access: care and monitoring of function. Nephrol Dial Transplant. 2001;16:1542–1545.
- Schindler R, Heemann U, Haug U, . Bismuth coating of non-tunneled hemodialysis catheters reduces bacterial colonization: a randomized controlled trial. Nephrol Dial Transplant. 2010;25:2651–2656.
- Baumann M, Witzke O, Dietrich R, . Prolonged catheter survival in intermittent hemodialysis using a less thrombogenic micro-patterned polymer modification. ASAIO J. 2003;49:708–712.
- Meier P, Meier R, Turini P, Friolet R, Blanc E. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micro-patterned polymer modification. Nephrol Dial Transplant. 2011;26:628–635.
- Parienti JJ, Thirion M, Mégarbane B, .; Members of the Cathedia Study Group. Femoral vs. jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299:2413–2422.
- Naka T, Egi M, Bellomo R, Baldwin I, Fealy N, Wan L. Resistance of vascular access catheters for continuous renal replacement therapy: an ex-vivo evaluation. Int J Artif Organs. 2008;31:905–909.
- Tan HK, Bridge N, Baldwin I, Bellomo R. An ex-vivo evaluation of vascular access catheters for continuous hemofiltration. Ren Fail. 2002;24:755–762.
- Unger JK, Haltern C, Portz B, Dohmen B, Gressner A, Rossaint R. Relation of hemofilter type to venous catheter resistance is crucial for filtration performance and hemocompatibility in CVVH – an in vitro study. Nephrol Dial Transplant. 2006;21:2191–2201.
- Unger JK, Pietzner K, Francis RC, . Dual lumen catheters for continuous veno-venous hemofiltration: limits for blood delivery via femoral vein access and a potential alternative in an experimental setting in anaesthetized pigs. Crit Care. 2007;11:R18.
- Parienti JJ, Mégarbane B, Fischer MO, .; Cathedia Study Group. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med. 2010;38:1118–1125.
- Brain M, Parkes S, Fowler R, Robertson I, Brown A. Calcium flux in continuous veno-venous hemofiltration with heparin and citrate anticoagulation. Crit Care Resusc. 2011;13:72–82.
- Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365:147–156.
- Agarwal B, Shaw S, Hari MS, Burroughs AK, Davenport A. Continuous renal replacement therapy in patients with liver disease: is circuit life different? J Hepatol. 2009;51: 504–509.
- Wright BJ. The RENAL replacement therapy study investigators. Intensity of continuous renal replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–1638.